Lawmakers question makers on key Vytorin meeting

Still trust drugs for your overweight/obesity?

"Two U.S. Democrats said on Friday their investigation had raised questions about how Merck & Co Inc and Schering-Plough Corp documented a key meeting about a controversial study of their Vytorin cholesterol drug.

House of Representatives Energy and Commerce Committee Chairman John Dingell and Rep. Bart Stupak said company documents showed minutes from a November meeting of outside experts reviewing the study were "created after the fact."

The documents showed one of the experts complained the minutes did not reflect all the opinions expressed, although he said a later summary did."

Give up the useless hope and do what works.